ARGININE FOR GLYCINE SUBSTITUTION IN THE TRIPLE-HELICAL DOMAIN OF THE PRODUCTS OF ONE ALPHA-2(I) COLLAGEN ALLELE (COL1A2) PRODUCES THE OSTEOGENESIS IMPERFECTA TYPE-IV PHENOTYPE

被引：1

作者：

WENSTRUP, RJ

COHN, DH

COHEN, T

BYERS, PH

机构：

[1] UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA

[2] UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA

[3] UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA

[4] HADASSAH UNIV HOSP, DEPT MED GENET, IL-91120 JERUSALEM, ISRAEL

来源：

JOURNAL OF BIOLOGICAL CHEMISTRY | 1988年 / 263卷 / 16期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：7734 / 7740

页数：7

共 50 条

[21] GENETIC-HETEROGENEITY OF MILD OSTEOGENESIS IMPERFECTA (O1 TYPE-I AND TYPE-IV) LINKAGE TO COL1A1, COL1A2 AND POSSIBLY OTHER LOCI
TSIPOURAS, P
CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 706 - 706
[22] A novel arginine-to-cysteine substitution in the triple helical region of the α1(I) collagen chain in a family with an osteogenesis imperfecta/Ehlers-Danlos phenotype
Lund, A. M.
Joensen, F.
Christensen, E.
Duno, M.
Skovby, F.
Schwartz, M.
CLINICAL GENETICS, 2008, 73 (01) : 97 - 101
[23] 2 ADDITIONAL CASES OF OSTEOGENESIS IMPERFECTA WITH SUBSTITUTIONS FOR GLYCINE IN THE ALPHA-2(I) COLLAGEN CHAIN - A REGIONAL MODEL RELATING MUTATION LOCATION WITH PHENOTYPE
WANG, Q
ORRISON, BM
MARINI, JC
JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (33) : 25162 - 25167
[24] OSTEOGENESIS IMPERFECTA TYPE-III - MUTATIONS IN THE TYPE-I COLLAGEN STRUCTURAL GENES, COL1A1 AND COL1A2, ARE NOT NECESSARILY RESPONSIBLE
WALLIS, GA
SYKES, B
BYERS, PH
MATHEW, CG
VILJOEN, D
BEIGHTON, P
JOURNAL OF MEDICAL GENETICS, 1993, 30 (06) : 492 - 496
[25] CLINICAL VARIABILITY OF OSTEOGENESIS IMPERFECTA LINKED TO COL1A2 AND ASSOCIATED WITH A STRUCTURAL DEFECT IN THE TYPE-I COLLAGEN MOLECULE
SUPERTIFURGA, A
PISTONE, F
ROMANO, C
STEINMANN, B
JOURNAL OF MEDICAL GENETICS, 1989, 26 (06) : 358 - 362
[26] SUBSTITUTION OF CYSTEINE FOR GLYCINE AT RESIDUE-415 OF ONE ALLELE OF THE ALPHA-1(I) CHAIN OF TYPE-I PROCOLLAGEN IN TYPE-III/IV OSTEOGENESIS IMPERFECTA
NICHOLLS, AC
OLIVER, J
RENOUF, DV
KESTON, M
POPE, FM
JOURNAL OF MEDICAL GENETICS, 1991, 28 (11) : 757 - 764
[27] SUBSTITUTION OF GLYCINE-172 BY ARGININE IN THE ALPHA-1 CHAIN OF TYPE-I COLLAGEN IN A PATIENT WITH OSTEOGENESIS IMPERFECTA, TYPE-III
MACKAY, K
DEPAEPE, A
NUYTINCK, L
DALGLEISH, R
HUMAN MUTATION, 1994, 3 (03) : 324 - 326
[28] USE OF ANTISENSE OLIGONUCLEOTIDES TO SELECTIVELY SUPPRESS PRODUCTION OF THE MUTANT ALPHA-2(I) CHAIN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS
MARINI, JC
WANG, Q
PEDIATRIC RESEARCH, 1994, 35 (04) : A153 - A153
[29] CHARACTERIZATION OF A TYPE-I COLLAGEN-ALPHA-2(I) GLYCINE-586 TO VALINE SUBSTITUTION IN OSTEOGENESIS IMPERFECTA TYPE-IV - DETECTION OF THE MUTATION AND PRENATAL-DIAGNOSIS BY A CHEMICAL CLEAVAGE METHOD
BATEMAN, JF
HANNAGAN, M
CHAN, D
COLE, WG
BIOCHEMICAL JOURNAL, 1991, 276 : 765 - 770
[30] Mixed osteogenesis imperfecta Ehlers-Danlos phenotype in a family with an exon 9 skipping mutation in the COL1A2 gene of type I collagen.
Nathanson, KL
Mills, J
Atkinson, M
Carpentieri, D
Byers, PH
Kaplan, P
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A108 - A108

← 1 2 3 4 5 →